Amicus Therapeutics competitorsClear all

Amicus Therapeutics's top competitors include Modis Therapeutics, Sanofi Genzyme, PhaseBio Pharmaceuticals and Paion.
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background
Amicus Therapeutics
Amicus Therapeutics
Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.
Modis Therapeutics
Modis Therapeutics
Modis Therapeutics develops treatments for rare genetic diseases.
Sanofi Genzyme
Sanofi Genzyme
Sanofi Genzyme (also known as Genzyme Corporation) is a biotech company that specializes in rare diseases, rare blood disorders, multiple sclerosis, oncology, and immunology.
PhaseBio Pharmaceuticals
PhaseBio Pharmaceuticals
PhaseBio Pharmaceuticals is a biopharmaceutical company committed to developing new and improved drugs, with an initial focus on endocrine and metabolic disorders and cardiovascular disease.
Paion
Paion
PAION is a biopharmaceutical company developing and commercializing drug candidates for diseases with substantial unmet medical needs.
Founding Date
Founding Date
2002
Founding Date
2016
Founding Date
1981
Founding Date
2002
Founding Date
2000
Type
Type
Public
Type
Subsidiary
Type
Subsidiary
Type
Public
Type
Public
Tags
Locations
Locations
Philadelphia, US HQ
Northbridge, AU
Pointe Claire, CA
Paris, FR
München, DE
Dublin, IE
Milano, IT
see more
Locations
Oakland, US HQ
Locations
Cambridge, US HQ
Macquarie Park, AU
Malaga, AU
Virginia, AU
São Paulo, BR
Mississauga, CA
Toronto, CA
see more
Locations
Malvern, US HQ
Locations
Aachen, DE HQ
Mönchengladbach, DE
Cambridge, GB
Employees
Employees
58415% increase
Employees
109% decrease
Employees
9,9041% decrease
Employees
22
Employees
3218% decrease
Valuation ($)
Valuation ($)
3.1 b
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
32.7 m
Valuation ($)
60.2 m
Twitter followers
Twitter followers
2 k
Twitter followers
N/A
Twitter followers
59.6 k
Twitter followers
298
Twitter followers
N/A
Number of tweets (last 30 days)
Number of tweets (last 30 days)
10
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
2
Number of tweets (last 30 days)
3
Number of tweets (last 30 days)
N/A
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
4.4
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
4.5
Average likes per tweet (last 30 days)
1.3
Average likes per tweet (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
66.67%
Percentage of tweets with engagement (last 30 days)
N/A
Alexa Website Rank
Alexa Website Rank
256484
Alexa Website Rank
N/A
Alexa Website Rank
N/A
Alexa Website Rank
637541
Alexa Website Rank
529818
Employee Rating
Employee Rating
2.9
Employee Rating
N/A
Employee Rating
N/A
Employee Rating
5
Employee Rating
3

Financial

Revenue (est.)
Revenue (est.)
$260.9m (FY, 2020)
Revenue (est.)
N/A
Revenue (est.)
€10.4b (FY, 2019)
Revenue (est.)
$320k (FY, 2020)
Revenue (est.)
€7.1m (FY, 2021)
Cost of goods
Cost of goods
$31m (FY, 2020)
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
(€1.5m) (FY, 2021)
Gross profit
Gross profit
$229.8m (FY, 2020)
Gross profit
N/A
Gross profit
N/A
Gross profit
N/A
Gross profit
€5.6m (FY, 2021)
Net income
Net income
($276.9m) (FY, 2020)
Net income
N/A
Net income
N/A
Net income
($98.6m) (FY, 2020)
Net income
(€21.8m) (FY, 2021)

Funding

Total funding raised
Total funding raised
$ 88m
Total funding raised
$ 30m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 15.2m
For sources of this data, please see the company profile

View company profiles

Modis Therapeutics
HQ
Oakland, US

Modis Therapeutics develops treatments for rare genetic diseases.

View company
Sanofi Genzyme
HQ
Cambridge, US

Sanofi Genzyme (also known as Genzyme Corporation) is a biotech company that specializes in rare diseases, rare blood disorders, multiple sclerosis, oncology, and immunology.

View company
PhaseBio Pharmaceuticals
HQ
Malvern, US
Employees
22

PhaseBio Pharmaceuticals is a biopharmaceutical company committed to developing new and improved drugs, with an initial focus on endocrine and metabolic disorders and cardiovascular disease.

View company
Paion
HQ
Aachen, DE
Employees
32↓ 18% decrease

PAION is a biopharmaceutical company developing and commercializing drug candidates for diseases with substantial unmet medical needs.

View company